SCHEMBL8515874

SCHEMBL8515874

CN(C)Cc1cccc(-c2cc(Nc3cccc(NS(C)(=O)=O)c3)ncn2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 10/20 0.67
CYP3A4 P08684 9/20 0.67
CYP2C19 P33261 7/20 0.67
CYP2D6 P10635 6/20 0.67
CLK4 Q9HAZ1 5/20 0.67
CYP2C9 P11712 5/20 0.67
USP2 O75604 4/20 0.67
TSHR P16473 2/20 0.67
ALDH1A1 P00352 6/20 0.61
HSD17B10 Q99714 5/20 0.61
MAPK1 P28482 4/20 0.58
KDM4E B2RXH2 2/20 0.58
HIF1A Q16665 2/20 0.58
HPGD P15428 1/20 0.58
TP53 P04637 2/20 0.56
ALOX15 P16050 1/20 0.56
CCNT1 O60563 3/20 0.55
CDK9 P50750 3/20 0.55
MAP4K4 O95819 1/20 0.55
CDK1 P06493 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8514815 0.90 CYP1A2 (0.65) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8515866 0.87 CYP3A4 (0.70) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL4435925 0.84 CCNT1 (0.61) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8513543 0.83 CYP1A2 (0.61) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8516577 0.83 CYP1A2 (0.86) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL17022950 0.82 CYP1A2 (0.63) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8513621 0.81 CYP1A2 (0.74) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL4109231 0.81 CCNT1 (0.77) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8514892 0.81 CYP1A2 (0.61) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL8516321 0.81 CYP1A2 (0.70) CYP1A2CYP3A4CYP2C19CYP2D6CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137166-B1 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2012-05-30 EP claimed